Oakes Gregory 4
4 · AzurRx BioPharma, Inc. · Filed Jan 6, 2021
Insider Transaction Report
Form 4
Oakes Gregory
Director
Transactions
- Award
Options (right to buy)
2021-01-04+41,237→ 41,237 totalExercise: $0.97Exp: 2031-01-03→ Common stock, par value $0.0001 per share (41,237 underlying)
Footnotes (1)
- [F1]The options vest in equal quarterly installments on each of March 31, 2021, June 30, 2021, September 30, 2021, and December 31, 2021.